Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Best Healthcare Stocks To Research - September 17th - Markets Daily
Biotech Stocks To Keep An Eye On - September 17th - Stock Observer
Moderna (NASDAQ:MRNA) Shares Up 1.3% - Should You Buy?
Stephen Hoge Sells 40,294 Shares of Moderna (NASDAQ:MRNA) Stock
Insider Selling: Moderna (NASDAQ:MRNA) President Sells $5,883,845.67 in Stock - Daily Political
Best Healthcare Stocks To Follow Today - September 16th - Stock Observer
Moderna (NASDAQ:MRNA) Shares Down 2% Following Insider Selling - Zolmax
Cboe data shows mixed options sentiment in Moderna with shares down 2.14%
Moderna (MRNA) Ascends While Market Falls: Some Facts to Note
Moderna (NASDAQ:MRNA) CFO Sells $4,685,093.64 in Stock
AI in healthcare advances melanoma treatment and drug repurposing | Fox News
Recent Analysts' Ratings Updates for Moderna (MRNA) - Stock Observer
Moderna's COVID Vaccine Was a Historic Success. Could Its Cancer Vaccine Be Even Bigger? - AOL
Congresswoman Bets on Elon Musk, Warren Buffett: Here's the Latest Stock Transactions
Moderna's Cancer Vaccine Win Fuels Broad Push Across Tumor Types
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033 | Morningstar
Rep. Maria Elvira Salazar Buys Shares of Moderna, Inc. (NASDAQ:MRNA) - Stock Observer
California State Teachers Retirement System Buys 27,274,128 Shares of Moderna, Inc. $MRNA
Moderna (NASDAQ:MRNA) Shares Up 6.7% - Should You Buy?
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat
New FDA Drug Approvals - August 2026
AI Discovers Revolutionary Lung Drug That Makes People 3 Years "Younger" After Just 4 Weeks of Use
Amundi Reduces Stock Holdings in Moderna, Inc. $MRNA
Healthcare Stocks To Add to Your Watchlist - September 10th - Stock Observer
Influenza A Market Insight, Epidemiology, and Market Forecast - 2036 Now Available - See Why a 70% Vaccine Failure Rate Is Fueling the Race for Next-Gen Flu Therapies
Murphy Pohlad Asset Management LLC Makes New Investment in Moderna, Inc. $MRNA - Markets Daily
West Virginia meat processor struggling under weight of tariffs & high beef prices
Cancer vaccines could transform treatment and prevention
Nykredit A S Invests $913,000 in Moderna, Inc. $MRNA
AI helps create drug that may slow down ageing by 6 years in few weeks
Swapped Lives: The 15-Year Fork in the Road Between Moderna and BioNTech
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
Promising Biotech Stocks To Consider - September 7th - Zolmax
The Second Act of Biotech
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
Moderna, Inc. (NASDAQ:MRNA) Receives Average Recommendation of "Hold" from Brokerages - Markets Daily
How Is Moderna's Stock Performance Compared to Other Healthcare Stocks
NEOS Investment Management LLC Purchases 5,811 Shares of Moderna, Inc. $MRNA - Daily Political
MRNA, PHVS and ABBV Stocks: 3 Healthcare Plays for the Next Week, Year and Decade
AlphaGrep UK Ltd Invests $568,000 in Moderna, Inc. $MRNA
Moderna (NASDAQ:MRNA) Cut to Sell at Rothschild & Co Redburn
Healthcare Stocks To Consider - September 5th - Stock Observer
Moderna, Inc. $MRNA is Step Capital Management Pte. Ltd.'s 2nd Largest Position - Markets Daily
Step Capital Management Pte. Ltd. Has $48.67 Million Stake in Moderna, Inc. $MRNA
22,477 Shares in Moderna, Inc. $MRNA Acquired by AXQ Capital LP
Moderna (MRNA) Stock Trades Above Fair Value After Its 479% Run
Proficio Capital Partners LLC Takes $298,000 Position in Moderna, Inc. $MRNA - Stock Observer
What Does Moderna (MRNA) Bird Flu Phase 3 Trial Mean For Its Growth?
Can anything bring sky-high airline prices down? The Points Guy weighs in
Moderna (MRNA) Stock Looks Expensive On Sales After A Very Large Run
Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?
Moderna's updated COVID-19 vaccine will target Omicron XFG variant
GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says
Healthcare Overtakes AI to Become Hedge Funds' Largest Holding
Why Moderna (MRNA) Stock Is Down Today
RGEN: Cancer Vaccine Exposure And Bioprocess Deals Will Shape Outlook
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?
Moderna (MRNA) Price Forecast: Bullish Pennant Points Toward Higher Targets
Moderna (NASDAQ:MRNA) Insider Sells $485,766.45 in Stock
Moderna (MRNA) Started A Phase 3 Bird Flu Vaccine Trial
Best Healthcare Stocks To Research - September 3rd
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?
3 Stocks Whose Competitive Walls Tower Over Nvidia's
This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks
Moderna (NASDAQ:MRNA) Shares Gap Down on Analyst Downgrade
Rothschild & Co Redburn Downgrades Moderna (NASDAQ:MRNA) to Sell
Here Are Thursday's Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More
Moderna is now overvalued after cancer vaccine-led stock surge, Rothschild & Co. says
Biotech Stocks To Follow Now - September 3rd - Daily Political
Domestically Developed Universal Immune Priming Therapy Launches Clinical Program - Targeting "Cold Tumors" Unresponsive to PD-1 Treatments
WHO's Tedros says Ebola response must be scaled up to tackle Congo outbreak
Updated COVID-19 vaccines are coming this fall. Will insurance cover them?
Jim Cramer Explains Why Heavily Shorted Moderna (MRNA) Has Room to Run
Is BioNTech Stock a No-Brainer Buy on the Dip?
Top Value Stocks To Follow Today - September 2nd - Stock Observer
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
US Stock Market Today: S&P 500 Futures Slip As Rising Yields Pressure Equities
Brookline Capital Markets Forecasts Moderna Q3 Earnings - Stock Observer
Did Merck's (MRK) First Positive Phase 3 Individualized mRNA Cancer Trial Just Redefine Its Moat?
Traders Buy Large Volume of Call Options on Moderna (NASDAQ:MRNA) - Markets Daily
Stock Market Today, Sept. 1: Stocks Slide and Oil Surges Amid U.S.-Iran Tension
New COVID-19 vaccines approved for 2026-27 to combat latest active viruses
Moderna Target of Unusually Large Options Trading (NASDAQ:MRNA) - Stock Observer
Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III
Moderna (NASDAQ:MRNA) Trading 3.6% Higher - Here's What Happened
GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trial
Moderna News
Gold Price Forecast 2026, 2027 and 2030: Can Gold Hold $4,200 After the Fed’s First Rate Hike Since 2023?
Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?
Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?
Latest news
Show more
EUR/USD Falls Toward Seven-Week Low as Hawkish Fed Lifts Dollar: Is 1.1350 Next?
Fed Raises Interest Rates for First Time Since 2023 as Dow Falls 631 Points
Gold Defies the Fed Rate Hike as Record Investment Demand Supports Bullion
